Baird Financial Group, Inc. Fulgent Genetics, Inc. Transaction History

Baird Financial Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$47.98 - $62.75 $154,015 - $201,427	-3,210 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$49.85 - $96.11 $14,356 - $27,679	-288 Reduced 8.23%	3,210 $200,000
Q4 2021 Feb 09, 2022	BUY	$77.3 - $105.0 $51,791 - $70,350	670 Added 23.69%	3,498 $352,000
Q3 2021 Nov 12, 2021	BUY	$74.87 - $110.87 $37,809 - $55,989	505 Added 21.74%	2,828 $254,000
Q2 2021 Aug 11, 2021	BUY	$66.8 - $100.45 $155,176 - $233,345	2,323 New	2,323 $214,000

200

16M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $554M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.